Results for tag: "Sirtuin 1"

Sirtuin 1 (SIRT1) is a protein that plays a role in regulating cell metabolism and is involved in the development of cancer. It is a target for oncology drugs, which are designed to inhibit the activity of SIRT1 in order to slow or stop the growth of cancer cells. SIRT1 inhibitors are being studied as potential treatments for a variety of cancers, including breast, lung, and colorectal cancer. The SIRT1 market is a rapidly growing field, with a number of companies developing drugs to target SIRT1. These companies include AstraZeneca, Merck, Novartis, and Pfizer, among others. These companies are investing heavily in research and development to create new drugs that can effectively target SIRT1 and improve the treatment of cancer. Show Less Read more